How many insider declarations has Russo Rene filed?

Russo Rene has filed 3 public insider declarations with SEC (Form 4).

What is Russo Rene's role?

Russo Rene's reported role is not specified by the regulator across the filings.

Which companies does Russo Rene report trades for?

Russo Rene reports trades for Xilio Therapeutics, Inc..

What is Russo Rene's declared buy vs sell volume?

Across the available history, declared buys total 21k€ and disposals 0.

← Executives ★ Sign in to follow

RR

Russo Rene

CEO

·SEC (Form 4)

Xilio Therapeutics, Inc.

0

Total declarations

0

Company

€21,366

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+9.4%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Discover the full record of transactions filed by Russo Rene. Director active across 1 company, notably Xilio Therapeutics, Inc.. In total, 3 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €21k. History available since 16 June 2025. The latest transaction was disclosed on 16 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Russo Rene

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Xilio Therapeutics, Inc. (US)

Declarations3 total

◇

Russo Rene

PRESIDENT AND CEOExecutives1 Jan 2026Xilio Therapeutics, Inc.

0SEC ↗

44,250 sharesCommon StockSEC:0001193125-26-002512:0

▲

Russo Rene

PRESIDENT AND CEOExecutives16 Jun 2025Xilio Therapeutics, Inc.

$24,68046SEC ↗

36,289 shares@ US$0.6801100.0% of flowCommon StockSEC:0001415889-25-017704:0

Canonical exit: 14 Sept 2025 (T+90)

◇

Russo Rene

PRESIDENT AND CEOExecutives1 Jan 2025Xilio Therapeutics, Inc.

0SEC ↗

44,250 sharesCommon StockSEC:0001415889-25-000405:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

RR

Russo Rene

CEO

·SEC (Form 4)

Xilio Therapeutics, Inc.

0

Total declarations

0

Company

€21,366

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+9.4%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Discover the full record of transactions filed by Russo Rene. Director active across 1 company, notably Xilio Therapeutics, Inc.. In total, 3 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €21k. History available since 16 June 2025. The latest transaction was disclosed on 16 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.